[DOI] [PubMed] [Google Scholar] 20.Ma Y, Wang X, Huang X, He Y, Su T, Niu X, Gao J, Lu F, Chang Q
Wegovy is FDA approved specifically for weight management in people with obesity or those who are overweight with a related condition like high blood pressure or sleep apnea
Future therapeutic testing should investigate whether a single-target therapy or combination therapy targeting oxidative stress is sufficient to overcome T21 cognitive impairment
Risk factors include the speed and magnitude of weight loss, pre-existing nutritional deficiencies, age, sex (women are more commonly affected), and individual genetic susceptibility
Our weight loss clinic offers personalized programs including Semaglutide, Tirzepatide, nutrition counseling, and long-term weight management